Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> CANTOR FITZGERALD Latest News

MAR 01, 2013 - Benzinga

A Must Read - Share

UPDATE: Cantor Fitzgerald Raises PT on Salix Pharmaceuticals on In-Line 4Q12 Results

In a report published Friday, Cantor Fitzgerald reiterated its Buy rating on Salix Pharmaceuticals Ltd. (NASDAQ: SLXP), and raised its price target from $60.00 to $63.00. Cantor Fitzgerald noted, “Salix reported revenues of $198M and nonGAAP EPS of $0.81 relative to $199M and $0.79 StreetAccount consensus.

Tags: UPDATE: Cantor Fitzgerald Raises PT on Salix Pharmaceuticals on In-Line 4Q12 Results,  Cantor Fitzgerald Latest News